谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Final Survival Outcomes and Exploratory Biomarker Analysis from the Randomized, Phase 2 Neoscore Trial: Two Versus Three Cycles of Neoadjuvant Sintilimab Plus Chemotherapy for Resectable Non-Small Cell Lung Cancer.

Fuming Qiu,Junqiang Fan,Miner Shao,Jie Yao,Lufeng Zhao,Ling Zhu,Baizhou Li,Yanbiao Fu,Lili Li,Mengyao Chen, Xinyi Zhang, Bangyi Zhou, Yixin Zhang,Huiying Liu,Jinglian Tu,Xiaoke Chen,Zuqun Wu,Zexin Chen

Journal of Clinical Oncology（2024）

引用 0|浏览6
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要